AF - 医索

找到约 508 条结果

Safety and efficacy of osimertinib plus consolidativestereotactic ablative radiation(SABR) inadvanced EGFR mutant non-small cell lungcancer(NSCLC)results from a multi-center Phase ltrial

医客学院 - 会议报告集

Lorlatinib vs Crizotinib in Treatment-NaivePatients With Advanced ALK Non-SmallCell Lung Cancer 5-Year Progression-FreeSurvival and Safety From the CRoWN Study

医客学院 - 会议报告集

Global Retrospective Study Comparing Consolidation ALK TKl to Durvalumab or Observation after Chemoradiation in Unresectable Locally Advanced ALK NSCLC

医客学院 - 会议报告集

Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas (DPM) Results of a prospective pilot study

医客学院 - 会议报告集

EFFICACY AND SAFETY OF TALETRECTINIB INPATIENTS WITH ADVANCED OR METASTATICROS1 NON-SMALL CELL LUNG CANCER THEPHASE 2 TRUST-I STUDY

医客学院 - 会议报告集

EFFICACY AND SAFETY OF SIGVOTATUGVEDOTIN, AN INVESTIGATIONAL ADC, IN NSCLCUPDATED PHASE 1 RESULTS(SGNB6A-001)

医客学院 - 会议报告集

Efficacy and Safety of Erdafitinib in Adults WithNSCLC and Prespecified Fibroblast Growth FactorReceptor Alterations in the Phase 2 Open-labelSingle-arm RAGNAR Trial

医客学院 - 会议报告集

Updated results from the Phase 1b2 HERKULES-3 studyERAS-007 plus encorafenib and cetuximab (Ec)inpatients (pts)with EC-naive metastatic BRAF V600Ecolorectal cancer (CRC)

医客学院 - 会议报告集

Three-year disease-free survival after transanal vsaparoscopic total mesorectal excision for rectalcancer (TaLaR)A randomized clinical trial

医客学院 - 会议报告集

一周饿两天，远离脂肪肝！Cell子刊：这种间歇断食法保护肝脏

间歇性禁食通常分为三类，一是“16+8”禁食法，每天进食8小时，其余16个小时禁食；二是“5:2禁食法”，即每周有规律的吃5天，另外2天少吃或禁食；第三种是隔日禁食。非酒精性脂肪肝病（NAFLD）是全球最常见的慢性肝病，它是中国.....

学术资讯 - 临床医学

今日实时热搜